U.S. Markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
432.72-0.73 (-0.17%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue4,860,4274,103,7282,819,557
Cost of Revenue299,694392,709205,018
Gross Profit4,560,7333,711,0192,614,539
Operating Expenses
Research Development2,052,2951,620,5771,271,353
Selling General and Administrative1,177,697838,526519,267
Non Recurring---
Total Operating Expenses---
Operating Income or Loss1,330,7411,251,916823,919
Income from Continuing Operations
Total Other Income/Expenses Net6,269-12,578-25,312
Earnings Before Interest and Taxes1,337,0101,239,338798,607
Interest Expense7,19514,24137,372
Income Before Tax1,329,8151,225,097761,235
Income Tax Expense434,293589,041423,109
Minority Interest---
Net Income From Continuing Ops895,522636,056338,126
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income895,522636,056338,126
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares895,522636,056338,126